Related Experiment Video
Updated: May 17, 2026

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals
Published on: September 20, 2021
Current status of HIV infection and ocular disease
Nicholas J Butler1, Jennifer E Thorne
1Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Insights
Highly active antiretroviral therapy (HAART) has changed HIV/AIDS ocular complications, but challenges like cytomegalovirus (CMV) retinitis persist, especially in advanced disease. Further research is needed on ocular syphilis and neuroretinal disorders in HIV patients.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Immunology
Background:
- Ocular complications remain a significant challenge for individuals with HIV/AIDS, despite advances in treatment.
- The landscape of HIV/AIDS-related eye disease has evolved with the advent of highly active antiretroviral therapy (HAART).
Purpose of the Study:
- To provide an updated review of ocular complications in HIV/AIDS patients.
- To focus on recent literature (past 12-18 months) concerning these challenges.
Main Methods:
- Literature review of recent studies (past 12-18 months).
- Analysis of current epidemiological data and clinical findings.
Main Results:
- Cytomegalovirus (CMV) retinitis incidence has decreased but remains a threat, particularly in patients with CD4 counts below 50 cells/μL.
- HIV patients may have an increased risk of posterior syphilitic uveitis.
- New ophthalmic imaging is revealing structural alterations in HIV-associated neuroretinal disorders.
Conclusions:
- Future efforts must identify additional risk factors for CMV retinitis.
- Further investigation into ocular syphilis and other infections in HIV patients is crucial.
- Understanding neuroretinal disorder structural changes can indicate other end-organ damage.
Purpose Of Review:
In the present era of highly active antiretroviral therapy (HAART), the challenges that HIV/AIDS patients face with regard to ocular complications has changed immensely; nonetheless, significant ocular morbidity persists. We present an update on these challenges, focusing particularly on the relevant literature from the past 12-18 months.
Recent Findings:
Although its incidence has decreased substantially in the HAART era, cytomegalovirus (CMV) retinitis remains an important cause of ocular morbidity and predictor of mortality. Presently, patients with less than 50 CD4 T-cells/μL have an approximately equal risk of developing this potentially blinding ocular complication compared with the pre-HAART era. Less is understood about the current epidemiological considerations of ocular syphilis and HIV; however, patients with HIV may have increased likelihood of posterior syphilitic uveitis. Regarding the neuroretinal disorder associated with HIV, new ophthalmic imaging modalities are helping to uncover potentially associated structural alterations.
Summary:
Future challenges in the fight against HIV/AIDS-related eye disease will involve identifying additional factors conferring increased risk of CMV retinitis, understanding the scope of ocular syphilis and other eye infections in HIV patients, and furthering our understanding of the structural changes in neuroretinal disorder as an indicator of other end-organ damage.
Related Concept Videos
Sexually Transmitted Infections
Glaucoma: Overview
Cytomegalovirus Disease
Microbiome of the Eye
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Retrovirus Life Cycles
